ClinicalTrials.Veeva

Menu

Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior

The Ohio State University logo

The Ohio State University

Status

Enrolling

Conditions

Behavior, Risk

Treatments

Behavioral: 3x3 between-subjects experimental exposure

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06192316
NCI-2023-08947 (Registry Identifier)
OSU-23115
U54CA287392 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study evaluates knowledge, feelings and thoughts regarding nicotine products among young adults who are susceptible to but do not use tobacco/nicotine and adults who use tobacco/nicotine.

Full description

PRIMARY OBJECTIVES:

I. Examine the effects of nicotine concentration and source claims on engagement with ONP packaging using laboratory-based psychophysiological assessment.

II. Examine the effects of nicotine concentration and source claims on participant self-reported ONP perceptions, behavioral intentions, and ONP trial.

This is an experimental behavioral study. Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.

Enrollment

450 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Young adult susceptible non-users aged 18-24 who have never used ONPs and have never used but are susceptible to using either:

    • combustible tobacco only (cigarettes, cigars, waterpipe)
    • non-combustible tobacco only (ST, ECs, heated tobacco products)
    • or both combustible and non-combustible tobacco (i.e., dual susceptibility)
  • Adult tobacco users aged 18-65 who have never used ONPs OR have used ONPs >3 months ago and 10 times or less in their lifetime. All adult tobacco users must also be:

    • exclusive combustible tobacco users

    • exclusive non-combustible tobacco users

    • dual users

      • For adult tobacco users, we will define current use as use of combustible and/or non-combustible tobacco every day or some days for 6 months or longer
  • Willing and able to complete an in-person lab visit.

Exclusion criteria

  • Age < 18 or > 65
  • Are not susceptible non-users or current tobacco users
  • Are unwilling or unable to complete and in person lab visit.
  • Have used ONPs within the past 3 months
  • Have used ONPs more than 10 times in their lifetime

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

450 participants in 9 patient groups

Nicotine Concentration: None Displayed; Nicotine Source Claim 1
Experimental group
Description:
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Treatment:
Behavioral: 3x3 between-subjects experimental exposure
Nicotine Concentration: None Displayed; Nicotine Source Claim 2
Experimental group
Description:
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Treatment:
Behavioral: 3x3 between-subjects experimental exposure
Nicotine Concentration: None Displayed; Nicotine Source Claim 3
Experimental group
Description:
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Treatment:
Behavioral: 3x3 between-subjects experimental exposure
Nicotine Concentration: Low; Nicotine Source Claim 1
Experimental group
Description:
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Treatment:
Behavioral: 3x3 between-subjects experimental exposure
Nicotine Concentration: Low; Nicotine Source Claim 2
Experimental group
Description:
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Treatment:
Behavioral: 3x3 between-subjects experimental exposure
Nicotine Concentration: Low; Nicotine Source Claim 3
Experimental group
Description:
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Treatment:
Behavioral: 3x3 between-subjects experimental exposure
Nicotine Concentration: High; Nicotine Source Claim 1
Experimental group
Description:
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Treatment:
Behavioral: 3x3 between-subjects experimental exposure
Nicotine Concentration: High; Nicotine Source Claim 2
Experimental group
Description:
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Treatment:
Behavioral: 3x3 between-subjects experimental exposure
Nicotine Concentration: High; Nicotine Source Claim 3
Experimental group
Description:
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Treatment:
Behavioral: 3x3 between-subjects experimental exposure

Trial contacts and locations

1

Loading...

Central trial contact

The Ohio State University Comprehensive Cancer Center

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems